Cas 856424-02-7,3-(2-methylcarbamoyl-pyridine-4-yloxy)-benzoic acid pentafluoro-phenyl ester

856424-02-7

Post Buying Request

Basic information

Product Name: 3-(2-methylcarbamoyl-pyridine-4-yloxy)-benzoic acid pentafluoro-phenyl ester
Synonyms: 3-(2-methylcarbamoyl-pyridine-4-yloxy)-benzoic acid pentafluoro-phenyl ester
CAS NO:856424-02-7
Molecular Formula:
Molecular Weight: 438.31
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(2-methylcarbamoyl-pyridine-4-yloxy)-benzoic acid pentafluoro-phenyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 3-(2-methylcarbamoyl-pyridine-4-yloxy)-benzoic acid pentafluoro-phenyl ester(856424-02-7)
EPA Substance Registry System: 3-(2-methylcarbamoyl-pyridine-4-yloxy)-benzoic acid pentafluoro-phenyl ester(856424-02-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 856424-02-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

856424-02-7 Suppliers

Recommended suppliers

856424-02-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 856424-02-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,6,4,2 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 856424-02:
(8*8)+(7*5)+(6*6)+(5*4)+(4*2)+(3*4)+(2*0)+(1*2)=177
177 % 10 = 7
So 856424-02-7 is a valid CAS Registry Number.

856424-02-7Upstream product

856424-02-7Downstream Products

856424-02-7Relevant academic research and scientific papers

PYRIDINAMIDE DERIVATIVE AS KINASE INHIBITORS

-

Page/Page column 53, (2010/02/14)

The invention relates to substituted arylamide derivatives of formula (I), to the production and use thereof for the production of a medicament for the treatment of diseases, in particular tumours and/or diseases which are provoked, transmitted and/or propagated by angiogenesis. Compounds of formula (I) are active inhibitors of tyrosine kinases, in particular TIE-2 and VEGFR, and the Raf-kinases.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 856424-02-7